Gynecological Oncology
  Female Pelvic Area Anatomy
  General Information...
     Overview of Cancer
     Diagnostic Procedures
     Diagnosis of Cancer
     Treatment Protocols...
        Surgery
        Radiation Therapy
        Chemotherapy
        Immunotherapy
        Hormone Therapy
        Clinical Trials
  Gynecological Cancers...
  Glossary
  Site Index

Related Resources Within UMM 
Greenebaum Cancer Center  
Women's Health Center  
Gynecological Oncology

Immunotherapy / Biological Therapy

What is immunotherapy / biological therapy?
Immunotherapy (also called biological therapy, biological response modifier therapy, or biotherapy) uses the body's immune system to fight cancer.

The cells, antibodies, and organs of the immune system work to protect or defend the body against foreign invaders, such as bacteria or viruses. Physicians and researchers found that the immune system may also be able to determine the difference between healthy cells and cancer cells in the body, and eliminate the cancer cells.

What are the immune system cells that fight cancer and other diseases?

  • lymphocytes - are white blood cells, including B cells, T cells, and NK cells.

  • B cells - become plasma cells that make antibodies or immunoglobulins.

  • T cells - produce cytokines, which control immune response.

  • NK cells - produce chemical substances that bind to and kill foreign invaders in the body.

  • monocytes - white blood cells that move into tissues and develop into macrophages, which, when needed, play a role in phagocytosis.

    Phagocytosis is a process in which some cells "eat" other cells or foreign invaders.

What is biological response modifier (BRM) therapy?
BRMs are substances that occur naturally in the body, such as cytokines or antibodies, which assist the body in fighting disease. BRMs can also be made in the laboratory. These created BRMs directly inhibit tumor cell growth, as well as assist the healthy cells in controlling the cancer. They have been successfully used in combination with each other and with other treatments. Some BRMs include:

  • interferons (IFNs)

  • interleukins (ILs)

  • tumor necrosis factors (TNFs)

  • colony-stimulating factors (CSFs)

  • monoclonal antibodies (MAOBs)

  • cancer vaccines



This content was last reviewed by a University of Maryland Medicine expert on
May 14, 2003


Translate this page
using Google Translator

to

 

UNIVERSITY OF MARYLAND MEDICINE
22 South Greene Street | Baltimore, MD 21201 
ph: 1-800-492-5538 | TDD: 410-328-9600 | Disclaimers
© 2003 UNIVERSITY OF MARYLAND MEDICAL SYSTEM
This site developed and maintained by Public Affairs. Information Guide